BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20870751)

  • 21. Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family.
    Hysolli E; Tanaka Y; Su J; Kim KY; Zhong T; Janknecht R; Zhou XL; Geng L; Qiu C; Pan X; Jung YW; Cheng J; Lu J; Zhong M; Weissman SM; Park IH
    Stem Cell Reports; 2016 Jul; 7(1):43-54. PubMed ID: 27373925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defined factors induce reprogramming of gastrointestinal cancer cells.
    Miyoshi N; Ishii H; Nagai K; Hoshino H; Mimori K; Tanaka F; Nagano H; Sekimoto M; Doki Y; Mori M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):40-5. PubMed ID: 20018687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive DNA demethylation preferentially up-regulates pluripotency-related genes and facilitates the generation of induced pluripotent stem cells.
    He S; Sun H; Lin L; Zhang Y; Chen J; Liang L; Li Y; Zhang M; Yang X; Wang X; Wang F; Zhu F; Chen J; Pei D; Zheng H
    J Biol Chem; 2017 Nov; 292(45):18542-18555. PubMed ID: 28924038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.
    Dal-Pra S; Hodgkinson CP; Mirotsou M; Kirste I; Dzau VJ
    Circ Res; 2017 Apr; 120(9):1403-1413. PubMed ID: 28209718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global epigenetic changes during somatic cell reprogramming to iPS cells.
    Mattout A; Biran A; Meshorer E
    J Mol Cell Biol; 2011 Dec; 3(6):341-50. PubMed ID: 22044880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanog, Oct4 and Tet1 interplay in establishing pluripotency.
    Olariu V; Lövkvist C; Sneppen K
    Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.
    Zhang X; Cruz FD; Terry M; Remotti F; Matushansky I
    Oncogene; 2013 May; 32(18):2249-60, 2260.e1-21. PubMed ID: 22777357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation-induced deaminase-coupled DNA demethylation is not crucial for the generation of induced pluripotent stem cells.
    Habib O; Habib G; Do JT; Moon SH; Chung HM
    Stem Cells Dev; 2014 Feb; 23(3):209-18. PubMed ID: 24083501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency.
    Pasque V; Tchieu J; Karnik R; Uyeda M; Sadhu Dimashkie A; Case D; Papp B; Bonora G; Patel S; Ho R; Schmidt R; McKee R; Sado T; Tada T; Meissner A; Plath K
    Cell; 2014 Dec; 159(7):1681-97. PubMed ID: 25525883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-302-Mediated Somatic Cell Reprogramming and Method for Generating Tumor-Free iPS Cells Using miR-302.
    Lin SL; Chen JS; Ying SY
    Methods Mol Biol; 2020; 2115():199-219. PubMed ID: 32006403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culturing of mouse and human cells on soft substrates promote the expression of stem cell markers.
    Higuchi S; Watanabe TM; Kawauchi K; Ichimura T; Fujita H
    J Biosci Bioeng; 2014 Jun; 117(6):749-55. PubMed ID: 24360205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein arginine methyltransferase 7-mediated
    Chen TY; Lee SH; Dhar SS; Lee MG
    J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RCOR2 is a subunit of the LSD1 complex that regulates ESC property and substitutes for SOX2 in reprogramming somatic cells to pluripotency.
    Yang P; Wang Y; Chen J; Li H; Kang L; Zhang Y; Chen S; Zhu B; Gao S
    Stem Cells; 2011 May; 29(5):791-801. PubMed ID: 21433225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small RNA-mediated regulation of iPS cell generation.
    Li Z; Yang CS; Nakashima K; Rana TM
    EMBO J; 2011 Mar; 30(5):823-34. PubMed ID: 21285944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NANOG priming before full reprogramming may generate germ cell tumours.
    Grad I; Hibaoui Y; Jaconi M; Chicha L; Bergström-Tengzelius R; Sailani MR; Pelte MF; Dahoun S; Mitsiadis TA; Töhönen V; Bouillaguet S; Antonarakis SE; Kere J; Zucchelli M; Hovatta O; Feki A
    Eur Cell Mater; 2011 Nov; 22():258-74; discussio 274. PubMed ID: 22071697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.